Dan Budwick - MergerLinks

target

INSITRO

bidder

Alexandria Venture Investments

£116m

38 dealmakers

United States

Biotechnology

Cross BorderAcquisitionMajorityPrivate EquityPrivate

target

Haystack Sciences

bidder

INSITRO

value n/a

6 dealmakers

United States

Biotechnology

MinorityPrivateCross BorderAcquisitionPrivate EquityVenture Capital

target

Day One Biopharmaceuticals

bidder

Ra Capital Management

£94m

11 dealmakers

United Kingdom

Pharmaceuticals

MinorityPrivate EquityAcquisitionPrivateCross BorderVenture Capital

target

Centessa Pharmaceuticals

bidder

Janus Henderson Investors

£179m

27 dealmakers

United States

Medical Services

DomesticPrivate EquityMinorityAcquisitionVenture CapitalPrivate

target

INSITRO

bidder

BLACKROCK

£287m

27 dealmakers

United States

Pharmaceuticals

DomesticMajorityMergerPrivate EquityDe-SPACAcquisitionPrivateReverse Takeover

target

EQRX

bidder

Bvf Partners

£2,622m

53 dealmakers

United States

Biotechnology

MinorityDomesticVenture CapitalAcquisitionPrivate EquityPrivate

target

Orbital Therapeutics

bidder

Newpath Partners

£216m

4 dealmakers

United States

Pharmaceuticals

DomesticMajorityAcquisitionPublic

target

Dice Therapeutics

bidder

Eli Lilly And Company

£1,874m

37 dealmakers

United States

Pharmaceuticals

Venture CapitalMinorityPrivateAcquisitionDomesticPrivate Equity

target

Mirador Therapeutics

bidder

Orbimed Advisors

£314m

7 dealmakers

Identify industry experts, connect with verified professionals, forge new relationships.